Roche Sells a 454 GS20 Sequencer to South African Biotech | GenomeWeb
NEW YORK (GenomeWeb News) — Roche e today said it has sold a 454 Life Sciences GS20 sequencer to the South African company Inqaba Biotechnical Industries. The deal includes the option to upgrade to a GS FLX.
 
Roche Diagnostics said it will provide Inqaba with support for the GS20’s applications.  
 
Inqaba said it was supported by BioPAD, a South African government-funded trust and shareholder designed to create a sequencing service in the region.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.